TRDA FY 2024 Earnings — Entrada Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TRDAEntrada Therapeutics, Inc.

$502M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$211M+63.4% YoY

Gross Profit

$211M100.0% margin

Operating Income

$47M22.3% margin

Net Income

$66M31.1% margin

EPS (Diluted)

$1.68

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$45M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$526M

Total Liabilities

$98M

Stockholders' Equity

$429M

Cash & Equivalents

$101M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$211M	$129M	+63.4%
Gross Profit	$211M	$129M	+63.4%
Operating Income	$47M	-$3M	+1586.7%
Net Income	$66M	-$7M	+1081.7%